Article ID Journal Published Year Pages File Type
4128019 Annales de Pathologie 2016 9 Pages PDF
Abstract
Loss of BAP1 expression is an indicator of MMD in a context of mesothelial proliferation. This immunohistochemistry could be integrated in the panel of immunostaining used for MMD diagnosis, either on histological or cytological samples. Furthermore, loss of BAP1 expression guides the patient to an oncology genetic counseling in order to eliminate a MMD developed as part of a constitutional genetic defect.
Related Topics
Health Sciences Medicine and Dentistry Pathology and Medical Technology
Authors
, , , , , , , , , , , ,